The device, bought during Boston Scientific’s acquisition of Silk Road Medical, has a risk of catheter tip separation during ...

Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access ...

The trial launch comes as Boston Scientific faces competitive pressures for pulsed-field ablation (PFA) market share.

Oct 25 (Reuters) - Boston Scientific's BSX.N quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could ...

Boston Scientific confirmed investors' worst fears Wednesday by cutting 2026 guidance for the second time this year. “This update today is not the outcome we planned or what you have come to expect ...

Boston Scientific cut its full-year outlook after two of its core heart-disease products faced unexpected challenges in the ...

(Reuters) - Boston Scientific's quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could take a hit ...